货号:GS40781
Veligrotug (VRDN-001) is an intravenous, human monoclonal antibody of the IgG1-kappa type that targets the insulin-like growth factor-1 receptor (IGF-1R). It is developed for the treatment of Thyroid Eye Disease (TED), where it works by blocking IGF-1R signaling to reduce inflammation, muscle swelling, and tissue expansion behind the eye.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
周璐